News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
74,093 Results
Type
Article (1926)
Company Profile (2)
Press Release (72165)
Section
Business (25332)
Career Advice (9)
Deals (4552)
Drug Development (8157)
FDA (1804)
Job Trends (799)
News (37020)
Policy (3562)
Tag
2027 BioCapital Standard (1)
Academia (101)
Accelerated approval (5)
ADA (2)
Allergies (26)
Alliances (8167)
ALS (22)
Alzheimer's disease (193)
Antibody-drug conjugate (ADC) (137)
Approvals (1991)
Artificial intelligence (40)
ASCO (37)
Autoimmune disease (42)
Automation (2)
Bankruptcy (9)
Best Places to Work (584)
BIO (9)
Biologics (5)
Biosimilars (105)
BioSpace Insights (1)
Biotechnology (5)
Bispecific (7)
Bladder cancer (33)
Brain cancer (8)
Breast cancer (67)
Cancer (707)
Cardiovascular disease (28)
Career advice (9)
CAR-T (19)
CDC (2)
CDMO (12)
Celiac Disease (1)
Cell therapy (68)
Cervical cancer (5)
Clinical research (7830)
Collaboration (361)
Commercialization (9)
Compensation (28)
Complete response letters (8)
COVID-19 (201)
CRISPR (1)
C-suite (116)
Cystic fibrosis (9)
Data (960)
Depression (18)
Dermatology (20)
Diabetes (53)
Diagnostics (660)
Digital health (8)
Drug discovery (46)
Drug pricing (1)
Duchenne muscular dystrophy (52)
Earnings (8278)
ESMO (39)
Events (7721)
Executive appointments (81)
Eye disease (1)
FDA (2378)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (172)
Gene editing (7)
Generative AI (1)
Gene therapy (44)
GLP-1 (87)
Government (248)
Grass and pollen (1)
Guidances (41)
Healthcare (1101)
Hematology (14)
HIV (7)
Huntington's disease (3)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (29)
Immunology and inflammation (7)
Immuno-oncology (14)
Indications (32)
Infectious disease (231)
Inflammatory bowel disease (26)
Inflation Reduction Act (1)
Influenza (14)
Intellectual property (44)
IPO (1640)
Job creations (241)
Job search strategy (9)
JPM (3)
Kidney cancer (2)
Kidney disease (10)
Layoffs (6)
Legal (953)
Licensing (22)
Liver cancer (22)
Longevity (3)
Lung cancer (134)
Lung diease (2)
Lymphoma (61)
Machine learning (1)
Manufacturing (158)
Marketing (8)
MASH (19)
Medical device (1180)
Medtech (1201)
Mergers & acquisitions (3129)
Metabolic disorders (128)
mRNA (9)
Multiple sclerosis (28)
NASH (1)
Neurodegenerative disease (39)
Neuropsychiatric disorders (7)
Neuroscience (376)
NextGen: Class of 2026 (218)
Non-profit (64)
Obesity (45)
Opinion (1)
Ovarian cancer (37)
Pain (24)
Pancreatic cancer (34)
Parkinson's disease (52)
Partnered (4)
Patents (81)
Patient recruitment (93)
Patient selection (12)
Peanut (2)
People (5238)
Peptides (1)
Pharmaceutical (2)
Pharmacy benefit managers (5)
Phase 1 (2110)
Phase 2 (3322)
Phase 3 (2960)
Pipeline (1538)
Policy (1)
Postmarket research (241)
Preclinical (714)
Press Release (2)
Prostate cancer (30)
Radiopharmaceuticals (29)
Rare diseases (100)
Real estate (606)
Regenerative medicine (4)
Regulatory (3136)
Reports (9)
Research institute (98)
Rett syndrome (1)
RNA editing (3)
RSV (3)
Schizophrenia (27)
Series A (38)
Series B (25)
Service/supplier (1)
Sickle cell disease (9)
Spinal muscular atrophy (5)
Sponsored (1)
Startups (425)
Stomach cancer (2)
Substance use disorders (2)
Supply chain (15)
Vaccines (49)
Venture capital (7)
Weight loss (20)
Women's health (9)
Date
Today (3)
Last 7 days (60)
Last 30 days (225)
Last 365 days (2853)
2026 (2330)
2025 (2685)
2024 (3253)
2023 (3817)
2022 (7007)
2021 (6373)
2020 (5871)
2019 (3860)
2018 (3011)
2017 (3558)
2016 (3172)
2015 (4029)
2014 (3020)
2013 (2600)
2012 (2775)
2011 (2903)
2010 (2663)
Location
Africa (90)
Alabama (5)
Arizona (14)
Arkansas (1)
Asia (22427)
Australia (2500)
California (895)
Canada (514)
China (577)
Colorado (6)
Connecticut (29)
Delaware (9)
Europe (13641)
Florida (97)
Georgia (18)
Hawaii (1)
Illinois (49)
India (67)
Indiana (35)
Japan (383)
Kansas (5)
Louisiana (2)
Maine (4)
Maryland (138)
Massachusetts (718)
Michigan (9)
Minnesota (41)
Missouri (3)
Nebraska (3)
Nevada (15)
New Hampshire (1)
New Jersey (573)
New York (307)
North Carolina (138)
Northern California (392)
Ohio (7)
Oregon (1)
Pennsylvania (168)
Puerto Rico (1)
Rhode Island (1)
South America (109)
South Carolina (1)
Southern California (436)
Tennessee (6)
Texas (68)
United States (3462)
Utah (37)
Vermont (1)
Virginia (71)
Washington D.C. (3)
Washington State (65)
Wisconsin (8)
Wyoming (1)
74,093 Results for "enamine ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Enamine contributes to the discovery of promising broad-spectrum coronavirus antiviral
October 21, 2025
·
3 min read
Genetown
Metrion Biosciences Enhances High Throughput Screening Services With Access to Enamine Compound Libraries
Metrion Biosciences Limited and Enamine Ltd announced that Metrion has enhanced its High Throughput Screening services with the addition of access to Enamine’s compound libraries.
April 11, 2024
·
2 min read
Press Releases
Femcare Ltd Acquires Orion Medical Supplies Ltd in the UK
August 31, 2026
·
2 min read
Press Releases
TempraMed Technologies Ltd. Announces Closing of Private Placement
October 1, 2026
·
5 min read
BioMidwest
Recursion and Enamine to Generate and Design Enriched Compound Libraries for Global Drug Discovery Industry
Recursion announced its partnership with Enamine, a world-renowned provider of novel molecules and contract research services, to generate enriched screening libraries with insights from Recursion’s protein-ligand interaction predictions spanning across Enamine’s massive library of 36 billion compounds.
December 20, 2023
·
6 min read
Press Releases
AV Laboratories Joins Regenivus (Mitrone Healthcare Ltd.) at Dublin’s Aesthetic & Regenerative Medicine Conference
October 18, 2026
·
3 min read
Press Releases
AVS Bio, an Arlington Capital Partners Portfolio Company, Acquires Biorbyt Ltd.
September 23, 2026
·
5 min read
Press Releases
Faron Pharmaceuticals Ltd: Holding(s) in Company - September 7, 2026
September 7, 2026
·
3 min read
Press Releases
Microbot Medical® and Medtechnica Ltd. Enter into Three-Year Exclusive Distribution Agreement in Israel
October 6, 2026
·
4 min read
SyntheticGestalt and Enamine to Collaborate on the Creation of AI-Based Model to Facilitate Drug Discovery
SyntheticGestalt and Enamine have announced the start of a joint effort to create a suite of AI models that will enable the generation of synthetically accessible biologically active compounds with optimized physicochemical and ADME/ Tox properties.
January 11, 2024
·
4 min read
1 of 7,410
Next
